“…After merging, a total of 37 studies [6,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59] were included in the NMA comparing adjuvant therapy after curative resection (NMA-2), with 14 different radio/chemotherapy regimens. For OS, there were 16 direct comparisons between different regimens with in total n = 10,761 patients (Figure 3).…”